METHODS FOR THE IDENTIFICATION OF INHIBITORS OF FERREDOXIN NADP OXIDOREDUCTASE EXPRESSION OR ACTIVITY IN PLANTS

Details for Australian Patent Application No. 2002319783 (hide)

Owner PARADIGM GENETICS, INC.

Inventors DAVIS, Keith; HAMILTON, Carol; WOESSNER, Jeffrey; GORLACH, Jorn; PHILLIPS, Kenneth; SEVALA, Veeresh; ZAYED, Adel; ASCENZI, Robert; BOYES, Douglas; MULPURI, Rao; HOFFMAN, Neil; KJEMTRUP, Susanne

Pub. Number AU-A-2002319783

PCT Number PCT/US02/25111

PCT Pub. Number WO2003/014401

Priority 60/310,395 06.08.01 US

Filing date 6 August 2002

Wipo publication date 24 February 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 001/26 Measuring or testing processes involving enzymes or micro-organisms - involving oxidoreductase

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/310,395 06.08.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002319783

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319784-DIGITAL EQUALIZATION PROCESS AND MECHANISM

2002319782-PARENTERAL FORMULATIONS OF 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PRY RAZOL3-YL)-3-(4-(2-MORPHOLIN-4-YL-ETH OXY)-NAPHTHALEN-1-YL)-UREA AND A CYCLODEXTRIN